Showing results (1691-1700 of 2,234) with videos related to
Sort By:
Pageof 224
Journal of Vascular Surgery|February 19, 2022
Perioperative care in open aortic vascular surgery: A consensus statement by the Enhanced Recovery After Surgery (ERAS) Society and Society for Vascular SurgeryKatharine L McGinigle, Emily L Spangler, Adam C Pichel, et al.Nature|November 3, 2006
Global distribution and conservation of rare and threatened vertebratesRichard Grenyer, C David L Orme, Sarah F Jackson, et al.Journal of Medicinal Chemistry|October 11, 2019
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-<i>trans</i>-Dihydro-1,2-diol Metabolites of the Utrophin Modulator EzutromidMaria Chatzopoulou, Tim D W Claridge, Kay E Davies, et al.BMC Infectious Diseases|December 1, 2019
Mathematical modelling for antibiotic resistance control policy: do we know enough?Gwenan M Knight, Nicholas G Davies, Caroline Colijn, et al.Journal of Medicinal Chemistry|July 26, 2002
Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivativesAshleigh E Gibson, Christine E Arris, Johanne Bentley, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2002
4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2Veronique Mesguiche, Rachel J Parsons, Christine E Arris, et al.Journal of Medicinal Chemistry|June 20, 2020
2-Arylbenzo[<i>d</i>]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular DystrophyArran Babbs, Adam Berg, Maria Chatzopoulou, et al.Nature Structural Biology|September 24, 2002
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitorThomas G Davies, Johanne Bentley, Christine E Arris, et al.European Journal of Medicinal Chemistry|June 21, 2023
Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell linesLaia Josa-Culleré, Sébastien R G Galan, Thomas J Cogswell, et al.European Journal of Medicinal Chemistry|April 29, 2021
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophyAini Vuorinen, Isabel V L Wilkinson, Maria Chatzopoulou, et al.Pageof 224